More recently, 90 HCC patients with PD-L1 expression in peritumoral hepatocytes were demonstrated to have a significantly higher risk of cancer recurrence or metastasis and cancer-related death [29]. The gene discussed is CD274; the disease is hepatocellular carcinoma.